StockGuru Spotlight on Novus Acquisition & Development Corp.
(Symbol: NDEV)
Help us update information on this company. Email any updates to: [email protected]
About Novus Acquisition & Development Corp.:
Novus is comprised of seasoned Wall Street Healthcare veterans that have focused its business model in Health and Wellness from physicians to patient treatment in the medical cannabis industry (MMJ). Management and its Board of Directors areas of expertise is diversified in Healthcare Management, Physicians Education, HMO, Pharma R&D, Compliance and Business Development. Since MMJ is not federally approved, NDEV focus is to mitigate risk through the development of our web portal, established regulatory protocol in the doctor patient relationship as a treatment option. NDEV is not in the business in cultivating, handle, transport grow, extract, dispense put up for sale, put on the market, vend, deliver, supply, circulate, trade, cannabis or any substances that violates the United States law or the Controlled Substances Act, nor does it intend to do so in the future and will continue to follow state and federal laws.
Where it is located:
13020 SW 92 Ave
Suite A310
Miami, FL
33176
United States
Key Executive Contact:
Victor Behar
Director, Bus. Dev.
Ninety Day Volume:
148551 (as of date of publication)
Ninety Day Dollar Volume:
$50,656
Share Information:
171013624 shares as of 2014-06-30
Corporate Information:
State Incorporated: NV
Country Incorporated: USA
Contact, Website and Social Media for Novus Acquisition & Development Corp.:
Shown Where Available
Website: http://www.ndev.biz
Facebook:
Twitter:
LinkedIn:
Telephone: 305-467-6699
Email: [email protected]
Investor Relations for Novus Acquisition & Development Corp.:
TackleBox Newswire
http://www.tackleboxnewswire.com